Breaking News

New Chief executive officer at Pierre Fabre USA

June 29, 2012



• Laboratoires Pierre Fabre: promoted Laurent-Emmanuel Saffré to president and chief executive officer of Pierre Fabre USA. In his new role, Saffré will oversee all pharmaceutical products and dermo-cosmetic brands, including René Furterer, Eau Thermale Avène, Glytone and Klorane, in the US in support of sustaining and growing Pierre Fabre’s worldwide renown in the realms of health and beauty.

Saffré holds a Doctor of Pharmacy degree, as well as a Master’s degree in management and marketing (ESSEC in 1996). Starting his career with Pierre Fabre in October 1996, Saffré represented A-Derma, a position pursued under the V.I.E status in the US within the Physicians Formula subsidiary. In 1998, he was promoted to vice president of the Americas. Saffré went on to join the PFDC Canada subsidiary in charge of marketing, becoming CEO of the subsidiary in 2003. In January 2008, Saffré was named manager of the Americas for the Dermo-Cosmetic branch.
  • Patent Activity: Colgate-Palmolive

    Patent Activity: Colgate-Palmolive

    December 6, 2016
    New oral care compositions, the use of radish root ferment filtrate in a cleanser and more.

  • Sparkle & Shine

    Sparkle & Shine

    Melissa Meisel, Associate Editor||November 21, 2016
    Glam packaging and upscale scent combos are big at Yankee Candle for Holiday 2016.

  • Cos Bar: Turning 40 and Hitting Fast Forward

    Cos Bar: Turning 40 and Hitting Fast Forward

    Christine Esposito, Associate Editor||November 21, 2016
    With a recent investor infusion, a new CEO and rebranding effort underway, this luxury beauty retailer has big plans.

  • The World Comes to Orlando

    The World Comes to Orlando

    Tom Branna , Editorial Director||December 1, 2016
    More than 1,600 chemists traveled to Florida for the IFSCC Congress

  • The Plex  Phenomenon

    The Plex Phenomenon

    Denise Costrini, Croda North America||December 1, 2016
    Croda details the hair-protecting qualities of bond multipliers and the company’s new bond-building formulation system.